{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:45:35Z","timestamp":1790729135137,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.531939","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T05:16:18Z","timestamp":1603084578000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps"],"prefix":"10.3389","volume":"11","author":[{"given":"Guilherme Diogo","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Borelli","family":"Del Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira","family":"de Oliveira Lelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9cio Figueira","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs:a 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/S1474-4422(14)70156-5","article-title":"Epilepsy surgery in children and adults","volume":"13","author":"Ryvlin","year":"2014","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1056\/NEJMra1407304","article-title":"Cannabinoids in the treatment of epilepsy","volume":"373","author":"Friedman","year":"2015","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science."},{"key":"B5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/epi.12610","article-title":"The case for medical marijuana in epilepsy","volume":"55","author":"Maa","year":"2014","journal-title":"Epilepsia."},{"key":"B6","doi-asserted-by":"publisher","first-page":"CD009270","DOI":"10.1002\/14651858.CD009270.pub3","article-title":"Cannabinoids for epilepsy","volume":"3","author":"Gloss","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1212\/WNL.0000000000000363","article-title":"Systematic review:efficacy and safety of medical marijuana in selected neurologic disorders:report of the guideline development subcommittee of the american academy of neurology","volume":"82","author":"Koppel","year":"2014","journal-title":"Neurology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/BF00450585","article-title":"Toward drugs derived from cannabis","volume":"65","author":"Mechoulam","year":"1978","journal-title":"Naturwissenschaften."},{"key":"B9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of cannabidiol to healthy volunteers and epileptic patients","volume":"21","author":"Cunha","year":"1980","journal-title":"Pharmacology."},{"key":"B10","first-page":"14","article-title":"Anticonvulsant effect of cannabidiol","volume":"69","author":"Ames","year":"1986","journal-title":"S Afr Med J."},{"key":"B11","article-title":"Double-blind clinical study of cannabidiol as a secondary anticonvulsant","volume-title":"Marijuana '90 International Conference on Cannabis and Cannabinoids","author":"Trembly","year":"1990"},{"key":"B12","first-page":"89","article-title":"An\u00e1lise cr\u00edtica 1do papel do canabidiol no tratamento da epilepsia","volume-title":"Epilepsia atual 1edS\u00e3o paulo 2018","author":"Pinto","year":"2018"},{"key":"B13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/oxfordjournals.jhered.a109475","article-title":"Inheritance of delta 9-tetrahydrocannabinol seizure susceptibility in rabbits","volume":"72","author":"Fish","year":"1981","journal-title":"J Hered."},{"key":"B14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0028-3908(82)90204-0","article-title":"Central excitatory properties of delta 9-tetrahydrocannabinol and its metabolites in iron-induced epileptic rats","volume":"21","author":"Turkanis","year":"1982","journal-title":"Neuropharmacology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1139\/y75-140","article-title":"Epileptiform seizures in domestic fowl. V. The anticonvulsant activity of delta9-tetrahydrocannabinol","volume":"53","author":"Johnson","year":"1975","journal-title":"Can J Physiol Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1528-1157.1975.tb06080.x","article-title":"Antiepileptic and prophylactic effects of tetrahydrocannabinols in amygdaloid kindled cats","volume":"16","author":"Wada","year":"1975","journal-title":"Epilepsia."},{"key":"B17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0014-2999(82)90264-3","article-title":"Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice","volume":"83","author":"Consroe","year":"1982","journal-title":"Eur J Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"428S","DOI":"10.1002\/j.1552-4604.1981.tb02623.x","article-title":"Antiepileptic potential of cannabidiol analogs","volume":"21","author":"Consroe","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids:delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.14581\/jer.17012","article-title":"Cannabinoids in the treatment of epilepsy: hard evidence at Last?","volume":"7","author":"Perucca","year":"2017","journal-title":"J Epilepsy Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.seizure.2012.03.001","article-title":"Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures","volume":"21","author":"Jones","year":"2012","journal-title":"Seizure."},{"key":"B22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy:an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/epi.13499","article-title":"Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex","volume":"57","author":"Hess","year":"2016","journal-title":"Epilepsia."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with lennox-gastaut syndrome (GWPCARE4):a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/jnnp-2017-317168","article-title":"Evidence for cannabis and cannabinoids for epilepsy:a systematic review of controlled and observational evidence","volume":"89","author":"Stockings","year":"2018","journal-title":"J Neurol Neurosur Psychiatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/epi.16546","article-title":"Cannabidiol efficacy and clobazam status:a systematic review and meta-analysis","volume":"61","author":"Lattanzi","year":"2020","journal-title":"Epilepsia."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1111\/epi.16355","article-title":"Coadministered cannabidiol and clobazam:preclinical evidence for both pharmacodynamic and pharmacokinetic interactions","volume":"60","author":"Anderson","year":"2019","journal-title":"Epilepsia."},{"key":"B30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/epi.14670","article-title":"Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study","volume":"60","author":"Thiele","year":"2019","journal-title":"Epilepsia."},{"key":"B31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/epi.14628","article-title":"Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial","volume":"60","author":"Devinsky","year":"2019","journal-title":"Epilepsia."},{"key":"B32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.yebeh.2019.03.042","article-title":"Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol","volume":"95","author":"Szaflarski","year":"2019","journal-title":"Epilepsy Behav."},{"key":"B33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S2215-0366(19)30048-3","article-title":"The contribution of cannabis use to variation in the incidence of psychotic disorder across europe (EU-GEI):a multicentre case-control study","volume":"6","author":"Di Forti","year":"2019","journal-title":"Lancet Psychiatry."},{"key":"B34","article-title":"Epidiolex (cannabidiol) in treatment resistant epilepsy","volume-title":"Conference: 67th Annual Meeting of the American-Academy-of-Neurology (AAN)","author":"Devinsky","year":"2015"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1111\/epi.16093","article-title":"Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy","volume":"60","author":"Birnbaum","year":"2019","journal-title":"Epilepsia."},{"key":"B36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/03602532.2013.849268","article-title":"Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes:a systematic review","volume":"46","author":"Stout","year":"2014","journal-title":"Drug Metab Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy","volume":"56","author":"Geffrey","year":"2015","journal-title":"Epilepsia."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1111\/epi.13852","article-title":"UAB CBD Program. Interactions between cannabidiol and commonly used antiepileptic drugs","volume":"58","author":"Gaston","year":"2017","journal-title":"Epilepsia"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1204","DOI":"10.1212\/WNL.0000000000005254","article-title":"Randomized, dose-ranging safety trial of cannabidiol in dravet syndrome","volume":"90","author":"Devinsky","year":"2018","journal-title":"Neurology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.7326\/M17-0155","article-title":"The effects of cannabis among adults with chronic pain and an overview of general harms:a systematic review","volume":"167","author":"Nugent","year":"2017","journal-title":"Ann Intern Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1471-0528.2002.01020.x","article-title":"Avon longitudinal study of pregnancy and childhood. maternal use of cannabis and pregnancy outcome","volume":"109","author":"Fergusson","year":"2002","journal-title":"BJOG."},{"key":"B42","unstructured":""},{"key":"B43","unstructured":""},{"key":"B44","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1111\/bcp.14038","article-title":"A systematic review of cannabidiol dosing in clinical populations","volume":"85","author":"Millar","year":"2019","journal-title":"Br J Clin Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.4155\/bio-2018-0184","article-title":"A UHPLC-MS\/MS method for the quantification of \u03949-tetrahydrocannabinol and cannabidiol in decoctions and in plasma samples for therapeutic monitoring of medical cannabis","volume":"10","author":"Barco","year":"2018","journal-title":"Bioanalysis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jchromb.2019.03.002","article-title":"Development and validation of an assay to measure cannabidiol and \u03949-tetrahydrocannabinol in human EDTA plasma by UHPLC-MS\/MS","volume":"1112","author":"Ocque","year":"2019","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"B47","volume-title":"Cannabidiol Tolerance in Children and Adults With Treatment-Resistant Epilepsy","author":"Uliel-Sibony","year":"2018"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1001\/jama.2015.6613","article-title":"Cannabinoid dose and label accuracy in edible medical cannabis products","volume":"313","author":"Vandrey","year":"2015","journal-title":"JAMA."},{"key":"B49","doi-asserted-by":"publisher","first-page":"10154","DOI":"10.1038\/s41598-018-30164-8","article-title":"Composition and use of cannabis extracts for childhood epilepsy in the australian community","volume":"8","author":"Suraev","year":"2018","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3389\/fneur.2019.01313","article-title":"Efficacy and tolerance of synthetic cannabidiol for treatment of drug resistant epilepsy","volume":"10","author":"Klotz","year":"2019","journal-title":"Front Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.531939\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T05:16:21Z","timestamp":1603084581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.531939\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":50,"alternative-id":["10.3389\/fneur.2020.531939"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.531939","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"article-number":"531939"}}